Roche’s test, which measures the blood level of pTau181, a protein that builds up in the brain tissue of Alzheimer’s patients ...

Preliminary data from first three patients in Phase 2b imaging clinical trial of RAD 101 show uptake in brain metastases from solid tumors, ...

Big brands aren’t always what they seem. From Michelin’s famed restaurant stars to electronics giants that started as noodle ...

SYMPLIFY, a prospective observational study, is the first large-scale evaluation of a multi-cancer early detection (MCED) test in individuals who presented with symptoms to primar ...

The SEQUOIA team is studying the use of entangled photons – pairs of quantum-linked light photons – to illuminate the retina.

Liposarcoma market growth is driven by increasing awareness and earlier diagnosis, expanding the pool of treatable patients. Advances in molecular ...

Juvenile Idiopathic Arthritis (JIA) is the most common rheumatic disease in children, affecting thousands of young patients ...

This week, Bobbi Conner talks with MUSC's Dr. Rebecca Leddy about your mammogram report and breast density details.

While rigorous, peer-reviewed validation is required, the technologies are promising, offering affordable, radiation-free ...

The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost ...